Sanitas cancels plant sale

Sanitas has terminated a proposed sale of a pharmaceutical manufacturing line and the plant associated with it. The firm explained that on 8th October 2012, it had applied to the Lithuanian Business Support Agency for permission to sell the assets; the firm had used EU assistance funds for the plant's acquisition and modernisation under an agreement made between it, the Lithuanian Ministry of Economy and the Lithuanian Business Support Agency in January 2005. However, Sanitas has revealed that no arrangements for the potential sale were concluded with any potential purchasers. The company commented that it would look for a new purchaser, but in the meantime the facility would continue in daily operation.

This article is tagged to:
Sector: Pharmaceuticals & Healthcare
Geography: Lithuania, Lithuania, Lithuania, Lithuania

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.